No Data
No Data
No Data
News On Graf Acquisition Corp. IV (GFOR) Now Under NKGN
News On Graf Acquisition Corp. IV (GFOR) Now Under NKGN
Press Release: Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination With NKGen Biotech, Inc. to September 25, 2023
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 25, 2023 PR Newswire THE WOODLANDS, Texas, Sept. 22, 2023 TH
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination With NKGen Biotech, Inc. to September 20, 2023
THE WOODLANDS, Texas, Sept. 14, 2023 /PRNewswire/ -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR.U, GFOR WS)) (the "Company" or "Graf"), announced today that on September 13, 2023, it adjourned, without
Press Release: Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination With NKGen Biotech, Inc. to September 13, 2023
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 13, 2023 PR Newswire THE WOODLANDS, Texas, Sept. 11, 2023 TH
Graf Acquisition Corp. IV Announces Intent to Adjourn Special Meeting to Approve Business Combination With NKGen Biotech, Inc. to September 8, 2023
THE WOODLANDS, Texas, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Graf Acquisition Corp. IV (NYSE:GFOR, GFOR-UN, GFOR-WT)) (the "Company" or "Graf"), announced today that it intends to adjourn, without conducting any business,
Graf Acquisition Corp. IV and NKGen Biotech, Inc. Announce Effectiveness of Form S-4 for Proposed Business Combination
No Data